TheEdgeResearch
Home / Stocks / AAXT

Aamaxan Transport Group, Inc. (AAXT)

OTC Healthcare Medical - Specialties
$0.00 ▼ -0.00%
Market Cap
$1,599
Sector
Healthcare
Industry
Medical - Specialties
Beta
32.32
52-Wk Range
0.000099999997-0.0001
CEO
Chen Zhong
Country
US
Currency
USD

Aamaxan Transport Group, Inc. operates in the Medical - Specialties industry of the Healthcare sector, headquartered in Shanghai, ON, US. The stock last traded at $0.00, down 0.00% on the session, giving a market capitalisation of $1,599. On trailing twelve-month figures it carries a trailing P/E of 0.00, a net margin of 0.0%. Its beta of 32.32 implies it has historically moved more than the broad market.

Valuation & profitability (TTM)
P/E
0.00
Price / Sales
0.00
Price / Book
0.00
EV / EBITDA
-0.05
Gross margin
0.0%
Operating margin
0.0%
Net margin
0.0%
Return on equity
Debt / equity
0.00
Current ratio
0.00
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
70
IPO date
1998-10-07
Headquarters
Shanghai, ON, US
About Aamaxan Transport Group, Inc.

Aamaxan Transport Group, Inc. manufactures medical products that are used during hemodialysis therapy. The company was founded as Shanghai Medical Technology Co., Ltd. and changed its name to Aamaxan Transport Group, Inc. in April 2008. The company is based in Shanghai, China.

Comparable companies

Aamaxan Transport Group, Inc. is most often compared with the following Healthcare names:

AABVFAASPAATVABMTAMGYBLUWWFONUICTY
More research on AAXT
AAXT technical analysis AAXT TheEdge Score Compare against peers
Open full interactive analysis & DCF →